Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

Table 2 Univariate and multivariate logistic regression models evaluating the impact of the YAP^pos/YAP^stroma phenotype on pCR (N = 61)

		Univariate regression model		Multivariate regression model^a
		OR (95 % CI)	p-value	OR (95 % CI)	p-value
Age	>49 vs ≤49	5.35 (1.51–19.03)	0.010	7.57 (1.81–31.65)	0.006
Stage	III vs II	0.65 (0.19–2.16)	0.481
Grade	III vs II	1.66 (0.54–5.12)	0.380
Ki-67	≥60 vs <60	0.23 (0.07–0.76)	0.016	0.24 (0.06–0.94)	0.041
YAP^pos/YAP^stroma	YAP^pos/YAP^stroma vs other combinations	5.23 (1.06–25.70)	0.042	7.13 (1.23–41.41)	0.029

ISSN: 1756-9966